Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech in the second half of 2024.

CEO/ C-suite/ Board

• CEO, Medtech (publicly listed), APAC
• CEO, Life science tools (publicly listed), Nordics
• President Life Sciences, Specialty chemicals (large-cap), UK & Ireland
• Chief Financial Officer Biotech (publicly listed), US
• Chief Financial Officer, Biopharma/ drug delivery (publicly listed), UK & Ireland
• Chief of Staff , Biopharma (publicly listed), Europe
• Chair, Mental health pharma (publicly listed), US/ UK

Commercial / Functional / Strategic Leadership

• VP, Artificial Intelligence, Drug discovery (publicly listed), UK & Ireland
• Head of Corporate Business Development, Pharma (mid-cap), Europe
• Country Launch Distribution Head , Specialty pharma (mid-cap), Europe
• Head of Human Resources Europe, Pharma (publicly listed), US
• Country Head of Market Access, Platform technology (publicly listed), Europe
• Director, Innovation and New Technologies, Biopharma (publicly listed), UK & Ireland
• Country Senior Director, Pricing and Market Access, Biotech (large-cap), US/ UK

R&D/ Medical/ Technical

• EVP/ Head of R&D/ Chief Medical Officer, Diversified pharma (publicly listed), US
• VP, Inflammation Rheumatology, Pharma (large-cap), US
• VP, Technical Operations, Drug technologies (mid-cap), Europe
• VP, Head of Obesity Development, Pharma (large-cap), US
• VP, Global Medical Affairs, Oncology, Pharma (large-cap), US
• Head of Quality Management, Biopharma (mid-cap), Europe
• Country Director, Medical Affairs, Pharma (mid-cap), Europe
• Director, Clinical Research, Specialty pharma (mid-cap), Europe
• Medical Director, Biopharma (publicly listed), US
• Quality Affairs Director, Animal health (large-cap), Europe